INTERCEPT PHARMACEUTICALS IN

CUSIP: 45845P108 Class: Common Stock

VOLORIDGE INVESTMENT MANAGEMENT, LLC's Holding History (CIK: 0001556921)

Note: Option positions (PUT/CALL) are excluded.

Q3 2023
Shares 56,353 Value ($000) $1,045 Avg Close — Range —
Q1 2023
Shares 166,327 Value ($000) $2,234 Avg Close — Range —
Q4 2022
Shares 270,441 Value ($000) $3,345 Avg Close — Range —
Q3 2022
Shares 333,729 Value ($000) $4,656 Avg Close — Range —
Q2 2022
Shares 312,476 Value ($000) $4,315 Avg Close — Range —
Q1 2022
Shares 301,213 Value ($000) $4,901 Avg Close — Range —
Q4 2021
Shares 235,996 Value ($000) $3,844 Avg Close — Range —
Q3 2021
Shares 282,062 Value ($000) $4,189 Avg Close — Range —
Q2 2021
Shares 323,236 Value ($000) $6,455 Avg Close — Range —
Q1 2021
Shares 360,685 Value ($000) $8,325 Avg Close — Range —
Q4 2020
Shares 371,324 Value ($000) $9,172 Avg Close — Range —
Q3 2020
Shares 314,839 Value ($000) $13,053 Avg Close — Range —
Q2 2020
Shares 34,402 Value ($000) $1,648 Avg Close — Range —
Q1 2020
Shares 26,472 Value ($000) $1,667 Avg Close — Range —
Q4 2019
Shares 27,801 Value ($000) $3,445 Avg Close — Range —
Q3 2019
Shares 3,390 Value ($000) $225 Avg Close — Range —
Q1 2019
Shares 5,574 Value ($000) $624 Avg Close — Range —
Q4 2018
Shares 10,875 Value ($000) $1,096 Avg Close — Range —
Q4 2017
Shares 16,424 Value ($000) $959 Avg Close — Range —
Q3 2017
Shares 8,191 Value ($000) $475 Avg Close — Range —